Back to EPRX
MARSHALL WACE, LLP EPRX Position History
Eupraxia Pharmaceuticals Inc. • Healthcare
Quarters held
8
Latest value
$1.2M
Q3 2026
Peak value
$1.2M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $174K |
| Q4 2025 | $1M |
| Q1 2026 | $166K |
| Q1 2026 | $979K |
| Q2 2026 | $152K |
| Q2 2026 | $893K |
| Q3 2026 | $209K |
| Q3 2026 | $1.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $1.2M | 135.2K | — | — |
| Q3 2026 | $209K | 23.0K | — | — |
| Q2 2026 | $893K | 135.2K | — | — |
| Q2 2026 | $152K | 23.0K | — | — |
| Q1 2026 | $979K | 135.2K | — | — |
| Q1 2026 | $166K | 23.0K | — | — |
| Q4 2025 | $1M | 135.2K | — | — |
| Q4 2025 | $174K | 23.0K | — | — |